Physician profile
Laura Lawrence
NPI 1346284627
$2,863.26
in general payments reported to CMS, 2019-2025
16 companies · $347 in 2025
The $347 reported for 2025 was more than what 81% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $260 · 2021: $443 · 2022: $420 · 2023: $449 · 2024: $457 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,160.82 | 2019-2025 | Menopur |
| Organon LLC | $510.15 | 2021-2025 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Merck Sharp & Dohme LLC | $237.33 | 2019-2021 | |
| Abbvie INC. | $218.64 | 2019-2021 | |
| Emd Serono, INC. | $197.42 | 2021-2025 | |
| Coopersurgical, INC. | $115.70 | 2020-2021 | |
| Astellas Pharma US INC | $111.36 | 2023-2024 | Veozah |
| Meditrina | $68.77 | 2022-2025 | |
| Mission Pharmacal Company | $53.43 | 2019-2024 | Citranatal, Citranatal Medley |
| Hologic Sales and Service, LLC | $38.03 | 2022-2023 | Myosure Tissue Removal Device |
| Galen US INC | $31.26 | 2020 | |
| Duchesnay USA Incorporated | $29.70 | 2019 | |
| Shield Therapeutics INC | $24.89 | 2024 | |
| Minerva Surgical, INC | $23.09 | 2021 | |
| Vertical Pharmaceuticals, LLC | $22.67 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $20.00 | 2024 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.